期刊簡介
Journal Title：Asia-pacific Journal Of Clinical Oncology
Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
中文簡介
《亞太臨床腫瘤學(xué)雜志》是一本多學(xué)科的腫瘤學(xué)雜志，旨在成為一個(gè)促進(jìn)合作和交流信息的論壇，以了解亞太地區(qū)不同國家在癌癥治療和護(hù)理方面的情況。該雜志非常適合發(fā)表與種族、文化、經(jīng)濟(jì)和其他人群差異有關(guān)的癌癥行為、管理和結(jié)果多樣性的出版物。除了原創(chuàng)文章外，該雜志還發(fā)表評(píng)論、社論、致編輯的信和簡短通訊。病例報(bào)告通常不考慮發(fā)表，只有編輯認(rèn)為具有非凡腫瘤學(xué)價(jià)值的優(yōu)秀論文才可能被考慮審閱。該雜志鼓勵(lì)臨床研究，尤其是前瞻性設(shè)計(jì)的臨床試驗(yàn)。
期刊點(diǎn)評(píng)
Asia-pacific Journal Of Clinical Oncology創(chuàng)刊于2005年，由WILEY出版商出版，影響因子指數(shù)2.012，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。
其他數(shù)據(jù)
| 是否OA開放訪問： | h-index： | 年文章數(shù)： |
| 未開放 | - | - |
| Gold OA文章占比： | 2021-2022最新影響因子（數(shù)據(jù)來源于搜索引擎）: | 開源占比（OA被引用占比）： |
| - | - | 0.11... |
| 研究類文章占比：文章 ÷（文章 + 綜述） | 期刊收錄： | 中科院《國際期刊預(yù)警名單（試行）》名單： |
| - | SCI、SCIE | 否 |
歷年引文指標(biāo)和發(fā)文量：
發(fā)文統(tǒng)計(jì)
2023-2024國家/地區(qū)發(fā)文量統(tǒng)計(jì)：
| 國家/地區(qū) | 數(shù)量 |
| Australia | 1151 |
| CHINA MAINLAND | 147 |
| USA | 106 |
| Japan | 61 |
| England | 54 |
| South Korea | 38 |
| Canada | 36 |
| Singapore | 32 |
| France | 28 |
| Taiwan | 28 |
2023-2024機(jī)構(gòu)發(fā)文量統(tǒng)計(jì)：
| 機(jī)構(gòu) | 數(shù)量 |
| UNIVERSITY OF SYDNEY | 234 |
| UNIVERSITY OF NEWCASTLE | 175 |
| PETER MACCALLUM CANCER CENTER | 144 |
| UNIVERSITY OF MELBOURNE | 109 |
| UNIVERSITY OF NEW SOUTH WALES SY... | 103 |
| HUNTER MEDICAL RESEARCH INSTITUT... | 102 |
| MONASH UNIVERSITY | 91 |
| UNIVERSITY OF QUEENSLAND | 88 |
| UNIVERSITY OF WESTERN AUSTRALIA | 77 |
| CALVARY MATER NEWCASTLE HOSPITAL | 76 |
近年引用統(tǒng)計(jì)：
| 期刊名稱 | 數(shù)量 |
| J CLIN ONCOL | 209 |
| ANN ONCOL | 84 |
| LANCET ONCOL | 80 |
| INT J RADIAT ONCOL | 75 |
| NEW ENGL J MED | 73 |
| CANCER-AM CANCER SOC | 72 |
| EUR J CANCER | 52 |
| EUR UROL | 43 |
| BRIT J CANCER | 41 |
| LANCET | 37 |
近年被引用統(tǒng)計(jì)：
| 期刊名稱 | 數(shù)量 |
| SUPPORT CARE CANCER | 24 |
| ASIA-PAC J CLIN ONCO | 23 |
| FRONT ONCOL | 23 |
| BMC CANCER | 18 |
| FUTURE ONCOL | 18 |
| BMJ OPEN | 15 |
| CANCERS | 15 |
| COCHRANE DB SYST REV | 15 |
| ONCOL LETT | 15 |
| MEDICINE | 14 |
近年文章引用統(tǒng)計(jì)：
| 文章名稱 | 數(shù)量 |
| Biomarkers and therapeutic advan... | 26 |
| Metastatic triple negative breas... | 17 |
| Strain-specific probiotic (micro... | 13 |
| PD-L1 expression associated with... | 13 |
| Identifying the most prevalent u... | 13 |
| The impacts of pretreatment circ... | 12 |
| Cancer multidisciplinary team me... | 11 |
| Exosomal tetraspanins as regulat... | 10 |
| Primary thromboprophylaxis (PTP)... | 10 |
| Clinical response to apatinib mo... | 9 |
更多問題
免責(zé)聲明
若用戶需要出版服務(wù)，請(qǐng)聯(lián)系出版商：Asia-Pac. J. Clin. Oncol.。